The largest database of trusted experimental protocols

Scgm media

Manufactured by CellGenix
Sourced in Germany, United States, Switzerland

SCGM media is a serum-free and chemically defined culture medium developed by CellGenix for the expansion and differentiation of a variety of cell types, including human and animal cells. It is optimized to support cell growth and maintain cell functionality.

Automatically generated - may contain errors

5 protocols using scgm media

1

Expansion of NK Cells from PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PM21 particles were generated and NK cells were expanded from peripheral blood mononuclear cells (PBMCs) as described previously.23 24 (link) Briefly, PBMCs were depleted of T-cells (EasySep CD3 positive selection kit; STEMCELL Technologies) and then cultured for up to 25 days with 100 U/mL interleukin-2 (IL-2; PeproTech) and 200 µg/mL of PM21 particles in SCGM media (CellGenix) supplemented with 10% non-HI FBS. PM21 particles were derived from CSTX-002 (K562-nmIL21-41BBL) cells, provided by Kiadis Pharma and maintained in RPMI media supplemented with 10% FBS.
+ Open protocol
+ Expand
2

Confrontation Assay for Neutrophil-Candida Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood of healthy volunteers was collected in ethylenediaminetetraacetic acid monovettes (Sarstedt). Polymorphonuclears (PMNs) were subsequently purified as described (67 (link),68 (link)). Immune cells were suspended in SCGM media (CellGenix), counted with a cellometer X2 (Nexcelom) and immediately subject to confrontation assay.
Confrontation of 3 × 106C. glabrata cells with 6 × 106 PMN was performed in one well of a 6-well plate (Corning) in a total volume of 3-ml SCGM media. Following the incubation period, 20-U DNase (Invitrogen) were added to the co-incubation to dissolve DNA based structures, which trapped fungal material. Co-incubations were flooded with five volumes of RNAlater (Ambion). The solution was mixed with an equal volume of 4°C H2O to lyse neutrophils. Fungal cells were harvested by centrifugation at maximum g for 5 min and subject to immediate RNA isolation.
+ Open protocol
+ Expand
3

Generating Cytokine-Activated NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Healthy donor peripheral blood mononuclear cells (Anne Arundel Medical Blood Donor Center, Annapolis, Maryland, USA; Carter Bloodcare, Woodway, Texas, USA) were isolated by Ficoll density gradient centrifugation and depleted of T cells using CD3 microbeads (Militenyi Biotec, Cologne, Germany). The remaining cells were stimulated on day (D)0 with lethally irradiated K562 feeder cells26 (link) expressing membrane bound IL-15 and 4-1BB ligand at a 1:1 ratio. Cells were maintained in SCGM media (CellGenix, Freiburg, Germany) supplemented with 10% fetal bovine serum, 2 mmol/L GlutaMAX (Thermo Fisher), and 200 IU/mL human interleukin (hIL)-2 (Biological Resources Branch Preclinical Biorepository, National Cancer Institute, Frederick, Maryland, USA). NK-cell purity was verified with flow cytometry using fluorophore conjugated antibodies against CD56 and CD3 (online supplemental table 1). NK cells were transduced on D4 of culture using transiently produced replication incompetent RD114 pseudotyped retroviral particles immobilized on RetroNectin (Clontech Laboratories, Palo Alto, California, USA).
+ Open protocol
+ Expand
4

Expansion of NK cells from PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PM21-particles were generated, and NK cells were expanded from peripheral blood mononuclear cells (PBMCs) as described previously [32 (link)]. Briefly, PBMCs were depleted of T-cells (EasySep CD3 selection kit; STEMCELL Technologies Inc., Vancouver CA) and then cultured for up to 25 days (d) with 100 U/mL Interleukin-2 (IL-2; Peprotech Inc., Cranbury, New Jersey, USA) and 200 μg/mL of PM21-particles in SCGM media (CellGenix, Freiburg im Breisgau, Germany) supplemented with 10% non-HI FBS. PM21 particles were derived from CSTX-002 (K562-nmIL21-41BBL) cells, provided by Kiadis Pharma, a Sanofi company and maintained in RPMI media supplemented with 10% FBS. PM21-NK cells were tested with target cells at different Effector:Target (E:T) cell ratios, to assure optimal cytotoxicity for different experimental conditions described in the text and to account for variations between donor NK cells.
+ Open protocol
+ Expand
5

Expansion of Enriched NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Enriched NK cells were cultured in SCGM media (Cellgenix®, Freiburg, Germany) supplemented with IL-2 (400 U/ml, Peprotech, Rocky Hill, NJ), 10% human serum (Sigma, St. Louis, MO), 10% heat-inactivated FBS, 100 U/ml penicillin, 100 U/ml streptomycin, 1% nonessential amino acids, 1% sodium pyruvate, 2 mM l-glutamine, and 10 mM HEPES. In experiments, NK cells were either used directly after blood isolation or after 7–30 days of ex vivo culture. Each scenario produced similar results.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!